RT Journal Article
SR Electronic
T1 Estimates of the Undetected Rate among the SARS-CoV-2 Infected using Testing Data from Iceland
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.06.20055582
DO 10.1101/2020.04.06.20055582
A1 Stock, James H.
A1 Aspelund, Karl M.
A1 Droste, Michael
A1 Walker, Christopher D.
YR 2020
UL http://medrxiv.org/content/early/2020/04/11/2020.04.06.20055582.abstract
AB Testing for SARS-CoV-2 in the United States is currently targeted to individuals whose symptoms and/or jobs place them at a high presumed risk of infection. An open question is, what is the share of infections that are undetected under current testing guidelines? To answer this question, we turn to COVID-19 testing data from Iceland. The criteria for testing within the Icelandic medical system, processed by the National University Hospital of Iceland (NUHI), have also been targeted at high-risk individuals, but additionally most Icelanders qualify for voluntary testing through the biopharmaceutical company deCODE genetics. We use results from Iceland’s two testing programs to estimate the share of infections that are undetected under standard (NUHI) testing guidelines. Because of complications in the deCODE testing regime, it is not possible to estimate a single value for this this undetected rate; however, a range can be estimated. Our primary estimates for the fraction of infections that are undetected range from 88.7% to 93.6%.Competing Interest StatementThe authors have declared no competing interest.Funding StatementAt the moment we have no external support for this project (which is in process). This material is based upon work supported by the National Science Foundation Graduate Research Fellowship under Grant No. 1122374.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data are publicly available. We use counts of tests and confirmed COVID-19 infections from the Icelandic Health Directorate's COVID-19 information website. We also use counts of cases reporting flu-like symptoms from the influenza website of the country's Health Directorate. We use quarantine numbers from the Department of Civil Defense's announcement page. https://www.landlaeknir.is/servlet/file/store93/item32967/influensulik.einkenni.uppfaersla.a.vef.okt2017.AG.xls_%C3%A1n%20myndar%20og%20aldursdreifingu.xls https://www.covid.is/data https://www.almannavarnir.is/utgefid-efni/